RECRUITING

AIMS Cancer Outcomes Study

Talk to us

Conditions

NeoplasmsNeoplasm MalignantAdvanced CancerAdvanced Solid TumorOncologyIntegrative OncologyNaturopathic OncologyPhytomedicineMetabolic TherapyImmunotherapy

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overall aim is to describe disease-free survival (DFS) in early stage cancer patients and three-year overall survival (OS) outcomes in advanced stage cancer patients receiving Advanced Integrative Oncology (AIO) treatment in a prospective consecutive case series outcomes study. We will collect data and study outcomes for patients with cancer who receive care at AIMS Institute.

Official Title

Advanced Integrative Oncology Treatment for Adult and Pediatric Patients With Cancer: A Prospective Outcomes Study

Quick Facts

Study Start:2020-05-18
Study Completion:2030-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04495790

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. A new patient coming in for a first office call (FOC) or first consultation via telemedicine with a diagnosis of cancer, or
  2. 2. An established patient with a diagnosis of cancer receiving treatment at the AIMS Institute;
  3. 3. If over 18 years of age are able to understand study design adequately and provide signed informed consent (IC) to enrollment;
  4. 4. If younger than 18 years of age informed assent from the child and informed consent from a parent or guardian who is able to understand the study design adequately and provide signed informed consent for the pediatric patient;
  5. 5. A confirmed diagnosis of cancer based on medical oncology medical records.
  1. 1. Patients not diagnosed with cancer;
  2. 2. Telehealth patients;
  3. 3. Cannot read or understand English well enough to read and sign the consent form and complete the questionnaires;
  4. 4. Unwilling to participate in the AIMS Institute observational study.

Contacts and Locations

Study Locations (Sites)

AIMS Institute
Seattle, Washington, 98102
United States

Collaborators and Investigators

Sponsor: Advanced Integrative Medical Science Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-05-18
Study Completion Date2030-12-31

Study Record Updates

Study Start Date2020-05-18
Study Completion Date2030-12-31

Terms related to this study

Keywords Provided by Researchers

  • Integrative Oncology
  • Naturopathic Oncology
  • Phytomedicine
  • Metabolic Therapy
  • Immunotherapy

Additional Relevant MeSH Terms

  • Neoplasms
  • Neoplasm Malignant
  • Advanced Cancer
  • Advanced Solid Tumor
  • Oncology